Finance

Lists
Why is SSKN up १००.००%?
Dive Deeper
SSKN:OTCMKTS
STRATA Skin Sciences Inc
US$ ०.०००२०
+१००.००%
(+०.०००१०) 1D
अक्टोबर ९, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SSKN...
Open
US$ ०.००
High
US$ ०.००
Low
US$ ०.००
Mkt. cap
५८८.८०
Avg. vol.
२.३६ हजार
Volume
१८२.००
52-wk high
US$ २.६५
52-wk low
US$ ०.००
EPS
-US$ १.३५
Beta
०.०६
Shares outstanding
५८.८८ लाख
No. of employees
११४
Open
US$ ०.००
High
US$ ०.००
Low
US$ ०.००
Mkt. cap
५८८.८०
Avg. vol.
२.३६ हजार
Volume
१८२.००
52-wk high
US$ २.६५
52-wk low
US$ ०.००
EPS
-US$ १.३५
Beta
०.०६
Shares outstanding
५८.८८ लाख
No. of employees
११४
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
२३ मिनेट पहिले
Prediction: This Brilliant ETF Will Crush the S&P 500 Over the Next 20 Years
Seeking Alpha
Seeking Alpha
·
३८ मिनेट पहिले
Buy 9 S&P500 IDEAL "Safer" October Dividend Dogs
Insider Monkey
Insider Monkey
·
१ घण्टा पहिले
Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?
Profile
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations. The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union. In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County. Wikipedia
About STRATA Skin Sciences Inc
CEO-
Employees११४
Founded१९८९ जनवरी १
HeadquartersHorsham Township, पेन्सिलभेनिया, संयुक्त राज्य अमेरिका
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
६८.१२ लाख
७६.६३ लाख
६९.२९ लाख
९२.९२ लाख
Cost of goods sold
३१.६५ लाख
३३.५७ लाख
२७.४५ लाख
३६.७८ लाख
Cost of revenue
३१.६५ लाख
३३.५७ लाख
२७.४५ लाख
३६.७८ लाख
Research and development expenses
९६.०० हजार
८६.०० हजार
१.७२ लाख
६७.०० हजार
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.६६ लाख
६४.४४ लाख
५८.६९ लाख
५५.१० लाख
Operating expense
५६.६२ लाख
६५.३० लाख
६०.४१ लाख
५५.७७ लाख
Total operating expenses
८८.२७ लाख
९८.८७ लाख
८७.८६ लाख
९२.५५ लाख
Operating income
-२०.१५ लाख
-२२.२४ लाख
-१८.५७ लाख
३७.०० हजार
Other non operating income
-
-
-
-
EBT including unusual items
-२४.३२ लाख
-२४.८९ लाख
-१६.२२ लाख
७०.०० हजार
EBT excluding unusual items
-२४.३२ लाख
-२४.८९ लाख
-२३.०६ लाख
-३.८१ लाख
Income tax expense
-
-
-
१२.०० हजार
Effective tax rate
-
-
-
१७.१४%
Other operating expenses
-
-
-
-
Net income
-२४.३२ लाख
-२४.८९ लाख
-१६.२२ लाख
५८.०० हजार
Net profit margin
-३५.७०%
-३२.४८%
-२३.४१%
०.६२%
Earnings per share
-०.५८
-०.६०
-०.३६
-
Interest and investment income
६९.०० हजार
२.२६ लाख
४९.०० हजार
६६.०० हजार
Interest expense
-४.८६ लाख
-४.९१ लाख
-४.९८ लाख
-४.८४ लाख
Net interest expenses
-४.१७ लाख
-२.६५ लाख
-४.४९ लाख
-४.१८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-७.९५ लाख
-१०.०६ लाख
-९.९३ लाख
८.५८ लाख
Gain or loss from assets sale
३४.०० हजार
२९.०० हजार
२०.०० हजार
९.०० हजार
AI content may include mistakes. Learn more
Google एपहरू